NCT07263906
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- The Second Affiliated Hospital,School of Medicine,Zhejiang University Hangzhou, Zhejiang, China
Clinical trial condition
Hematologic Diseases
Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.
15,385 public trials
2,846 recruiting studies
Hematologic Diseases trial results
NCT03300492
- Conditions
- Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
- Locations
-
- University Hospital Basel Basel, Switzerland
NCT05194397
- Conditions
- Anemia, Anemia, Aplastic, Aplastic Anemia, +27 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
Recruiting
A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma
NCT06049290
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- The First Affiliated Hospital of Wannan Medical College Wuhu, Anhui, China
- Peking University People's Hospital Beijing, Beijing Municipality, China
- Peking University Shougang Hospital Beijing, Beijing Municipality, China
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
NCT06237803
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Extramedullary Myeloma, +20 more
- Locations
-
- Alfred Hospital Melbourne, Australia
- KUK Linz Linz, Austria
- Medical University Vienna Vienna, Austria
- Department of Haematology UZ Leuven Gasthuisberg Leuven, Belgium
NCT06645678
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- National University Hospital (NUH) Singapore
- Singhealth Duke NUS blood cancer center Singapore
- Chonnam National University Hwasun Hospital Hwasun, South Korea
- Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea
Recruiting
Phase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
NCT06920251
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT04844528
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
NCT06485076
- Conditions
- Aggressive Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +22 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
Recruiting
Dupilumab Therapy for EGIDs
NCT07257835
- Conditions
- Digestive System Diseases, Eosinophilia, Eosinophilic Esophagitis, +11 more
- Locations
-
- 201102 Shanghai, China